Posted in | News | Laser

FARO Introduces Affordable, Short-Range Laser Scanner

FARO Technologies, Inc., the world's most trusted source for 3D measurement and realization technology, announces the release of the new FARO Focus3D X 30 Laser Scanner. With a scanning range of up to 30 meters, the Focus3D X 30 is ideal for a variety of short-range scanning applications such as architectural preservation, as-built documentation, building information modelling (BIM), engineering, facility management and forensics.

The ultra-portable Focus3D X 30 enables fast, straightforward and accurate measurements of interiors, such as small architectural façades, complex structures, crime scenes, mechanical rooms, and production and supply facilities. Combining high-precision scanning technology with true mobility and ease-of-use, the Focus3D X 30 offers reliability, flexibility, and real-time views of recorded data. As with the entire range of laser scanners from FARO, the Focus3D X 30 features a Class 1 "eye-safe" laser.

"Usability and high return on investment are at the core of FARO's Focus3D X 30 product," noted Joe Arezone, Senior Vice President and Managing Director of FARO Europe and Asia Pacific. "With its feature set and price point tailored to short-range scanning projects, it is a powerful and effective tool for customers working in challenging economic environments."

With the introduction of the Focus3D X 30, FARO offers its customers a choice between the short-range Focus3D X 30 (30 meters), the mid-range Focus3D X 130 (130 meters) or the long-range Focus3D X 330 (330 meters) Laser Scanner.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks and uncertainties, such as statements about demand for and customer acceptance of FARO's products, and FARO's product development and product launches. Statements that are not historical facts or that describe the Company's plans, objectives, projections, expectations, assumptions, strategies, or goals are forward-looking statements. In addition, words such as "is," "will," "continues" and similar expressions or discussions of FARO's plans or other intentions identify forward-looking statements. Forward-looking statements are not guarantees of future performance and are subject to various known and unknown risks, uncertainties, and other factors that may cause actual results, performances, or achievements to differ materially from future results, performances, or achievements expressed or implied by such forward-looking statements. Consequently, undue reliance should not be placed on these forward-looking statements.

Factors that could cause actual results to differ materially from what is expressed or forecasted in such forward-looking statements include, but are not limited to:

  • development by others of new or improved products, processes or technologies that make the Company's products less competitive or obsolete;
  • the Company's inability to maintain its technological advantage by developing new products and enhancing its existing products;
  • declines or other adverse changes, or lack of improvement, in industries that the Company serves or the domestic and international economies in the regions of the world where the Company operates and other general economic, business, and financial conditions; and
  • other risks detailed in Part I, Item 1A. Risk Factors in the Company's Annual Report on Form 10-K for the year ended December 31, 2014.

Forward-looking statements in this release represent the Company's judgment as of the date of this release. The Company undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events, or otherwise, unless otherwise required by law.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.